Moonlake Immunotherapeutics (MLTX)
38.00 x 1 41.16 x 2
Post-market by (Cboe BZX)
40.18 +1.03 (+2.63%) 04/29/25 [NASDAQ]
38.00 x 1 41.16 x 2
Post-market 39.31 -0.87 (-2.17%) 16:00 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | MLTX | IMVT | ACAD | ||
| Company | Moonlake Immunotherapeutics | Immunovant Inc | Acadia Pharmaceutica | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.20 | 15.42 | 14.66 | ||
| High | 40.44 | 15.86 | 14.68 | ||
| Low | 38.26 | 15.15 | 14.38 | ||
| Last | 40.18 | 15.22 | 14.43 | ||
| Change | +1.03 | -0.20 | -0.23 | ||
| % Change | +2.63% | -1.30% | -1.57% | ||
| Volume | 1,337,900 | 1,213,700 | 1,587,100 | ||
| 20-Day Average Volume | 489,705 | 2,138,335 | 1,726,900 | ||
| Previous Close | 39.15 | 15.42 | 14.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.36 | 14.93 | 14.90 | ||
| 20-Day Raw Stochastic | 91.73% | 57.21% | 30.56% | ||
| 20-Day Relative Strength | 53.16% | 43.10% | 38.40% | ||
| Weighted Alpha | -14.83 | -53.40 | -19.27 | ||
| Today's Opinion | 64% Sell | 88% Sell | 88% Sell | ||
| Previous Opinion | 64% Sell | 88% Sell | 56% Sell | ||
| Last Month's Opinion | 72% Sell | 100% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.85% since 04/22/25 | +6.81% since 04/22/25 | +0.56% since 04/22/25 | ||
| Low | 38.20 on 04/25/25 | 14.36 on 04/23/25 | 14.26 on 04/28/25 | ||
| High | 40.89 on 04/23/25 | 15.86 on 04/29/25 | 15.02 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +0.80% since 03/28/25 | -17.15% since 03/28/25 | -15.47% since 03/28/25 | ||
| Low | 31.42 on 04/09/25 | 12.72 on 04/09/25 | 13.40 on 04/09/25 | ||
| High | 40.97 on 04/22/25 | 17.81 on 03/31/25 | 16.88 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | -12.77% since 01/29/25 | -30.15% since 01/29/25 | -21.45% since 01/29/25 | ||
| Low | 31.42 on 04/09/25 | 12.72 on 04/09/25 | 13.40 on 04/09/25 | ||
| High | 48.54 on 02/07/25 | 23.10 on 02/06/25 | 20.68 on 02/21/25 | ||
| 6-Month | |||||
| %Chg | -16.62% since 10/29/24 | -49.06% since 10/29/24 | -2.10% since 10/29/24 | ||
| Low | 31.42 on 04/09/25 | 12.72 on 04/09/25 | 13.40 on 04/09/25 | ||
| High | 58.26 on 12/17/24 | 32.10 on 11/06/24 | 20.68 on 02/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,506,070 | 2,619,257 | 2,445,127 | ||
| Shares Outstanding, K | 64,012 | 169,861 | 166,789 | ||
| Annual Sales | 0 | 0 | 957,800,000 | ||
| Annual Net Income | -118,940,000 | -259,340,000 | 226,450,000 | ||
| Last Quarter Sales | 0 | 0 | 259,600,000 | ||
| Last Quarter Net Income | -45,600,000 | -111,120,000 | 143,740,000 | ||
| 60-Month Beta | 1.32 | 0.81 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 02/26/25 | -0.76 on 02/06/25 | 0.17 on 02/26/25 | ||
| Latest Earnings Date | 05/06/25 | 06/04/25 | 05/07/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 21.99 | ||